Last Updated on September 30, 2024 by The Health Master
USFDA approval
AstraZeneca has secured a major victory in the fight against lung cancer. The US Food and Drug Administration approval (USFDA approval) has granted to the company’s blockbuster drug, Imfinzi, for the treatment of patients with a specific type of non-small cell lung cancer.
Imfinzi: A New Hope for Lung Cancer Patients
This USFDA approval marks a significant milestone in lung cancer treatment.
Imfinzi will now be administered as an additional therapy following surgery for adult patients diagnosed with non-small cell lung cancer.
It’s worth noting that the drug is already a proven treatment for advanced-stage lung cancer, where surgical removal is not feasible.
Boost for AstraZeneca: Imfinzi Drives Stock Surge
The positive news from the USFDA sent shockwaves through the financial market.
AstraZeneca’s share price soared to a record high of 130.48 pounds, fueled by the USFDA’s priority review for Imfinzi’s use in treating limited-stage small cell lung cancer.
How Does Imfinzi Work?
Imfinzi is a cutting-edge immunotherapy drug.
It works by targeting and neutralizing a protein that helps cancer cells evade the immune system.
By blocking this protein, Imfinzi empowers the body’s natural defenses to fight cancer more effectively, offering a promising alternative to traditional chemotherapy treatments.
The USFDA approval of Imfinzi for earlier-stage lung cancer is a testament to ongoing advancements in cancer research.
It brings new hope to countless patients and underscores AstraZeneca’s commitment to developing innovative therapies to combat this deadly disease.
Disclaimer: This article contains information derived from the source mentioned below. Our team utilized an AI language model to rewrite and present the news or article in a unique format.
USFDA approval granted for Valbenazine Capsules
USFDA approval granted for Trazodone tablets
USFDA approval granted for Acitretin Capsules USP
USFDA approval granted for drug against Baldness
USFDA approval granted for Valsartan Tablets
USFDA approval granted for Fluphenazine Hydrochloride Tablets USP
Drug recall: B. Braun recalls Saline Solution due to this reason
USFDA issues warning letter to Eugia Pharma subsidiary of Aurobindo
Govt Job: For the post of Director at (RDTL) Regional Drugs Testing Laboratory
Govt ban on Pain relief combination S(+)Etodolac & Paracetamol
Phase 3 Clinical Trial for Indigenous Dengue Vaccine Begins in India
NPPA revised Ceiling price of 4 scheduled formulation: August 2024
Saudi FDA fines 6 Pharma Companies for violating Law
USFDA new norms on Container Closure System: A Boon for Indian Pharma?
Draft guidelines issued for Good Distribution Practices for Pharmaceuticals
For informative videos by The Health Master, click on the below YouTube icon:
For informative videos on Medical Store / Pharmacy, click on the below YouTube icon:
For informative videos on the news regarding Pharma / Medical Devices / Cosmetics / Homoeopathy etc., click on the below YouTube icon:
For informative videos on consumer awareness, click on the below YouTube icon:
